You are here

Algernon Pharmaceuticals Inc.

Listing Exchange: 
CSE
Status: 
Active
Industry: 
Life Sciences
Symbol: 
AGN
CSE Index: 
Currency: 

Algernon Pharmaceuticals is a clinical stage pharmaceutical development company focused on advancing its lead compounds for non–alcoholic steatohepatitis (NASH), chronic kidney disease (CKD) inflammatory bowel disease (IBD), idiopathic pulmonary fibrosis (IPF) and chronic cough.

You are here

Algernon Pharmaceuticals Inc. (AGN)

SEDAR Information

Company Info

Address
Suite 900 - 700 West Pender Street
Vancouver, BC V6C 1G8
Canada
Phone
604-398-4175
Ext
701
Email
chris@algernonpharmaceuticals.com
Website
http://www.algernonpharmaceuticals.com
Listing date
Monday, February 1, 2016
Transfer Agent
AST Trust Company (Canada)
Auditor
Smythe LLP

Advertisement

Publicité

Capitalization

Issued & Outstanding: 
103,837,697
Reserved for Issuance: 
45,036,567

Bulletins

14/02/2019

2019-0226 – Name and Symbol Change - Breathtec Biomedical Inc. (BTH)

Le 14 février/February 2019

Breathtec Biomedical Inc. (BTH)  has announced a name and symbol change to Algernon Pharmaceuticals Inc. (AGN).

Shares will begin trading under the new name and symbol on February 19, 2019.

Advertisement

Publicité

Latest CSE News

Upcoming Events

05-27_Virtual_Industry_Updates_The_Business_of_Esports_Website

Virtual Industry Updates: The Business of Esports

Wednesday, May 27, 2020 -
3:00pm to 4:15pm
06-10_Virtual_Industry_Updates_The_Rise_of_the_Psychedelics_Sector_Website

Virtual Industry Updates: The Rise of the Psychedelics Sector

Wednesday, June 10, 2020 -
3:00pm to 4:15pm
06-17_Investing_in_Psychedelics_Website_V2

Investing in Psychedelics

Wednesday, June 17, 2020 -
11:00am to 2:00pm